Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel versus vinorelbine in poor performance status non-small cell lung cancer
ACTRN12610000020088Phase 2Completed
- Sponsor
- HeCOG
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Oral vinorelbine with Paclitaxel (2 arms). Primary endpoint: Clinical benefit. Started Jun 2004; status: completed.
02
Drugs
paclitaxelvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ACTRN12610000020088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000020088.